|
Nephrocare Health Services Ltd
|
|
cs@nephroplus.com Website:www.nephroplus.com
|
|
Initial public offering of up to [*] equity shares of face value of Rs.2/- each ("Equity Shares") of Nephrocare Health Services Limited ("the Company" or the "Company" or the "Issuer") for cash at a price of Rs.[*] per equity share face value of Rs.2/- (Including a Securities Premium of Rs.[*] per Equity Share) ("Offer Price") aggregating up to Rs.[*] crores ("Offer") comprising a fresh issue of [*] equity shares of face value of Rs.2/- each aggregating up to Rs.353.41 crores ("Fresh Issue") and an offer for sale of up to 1,12,53,102 equity shares of face value of Rs.2/- each ("Offered Shares") aggregating up to Rs.[*] crores, comprising an offer for sale of up to 1,521,728 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Investcorp Private Equity Fund ii and up to 1,604,907 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Healthcare Parent Limited and up to 147,765 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Investcorp Growth Opportunity Fund and up to 2,888,911 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Edoras Investment Holdings Pte. Ltd. ("Promoter Selling Shareholders") and up to 121,985 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Investcorp India Private Equity Opportunity Limited and up to 3,089,663 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by International Finance Coproration and up to 1,433,468 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by 360 One Special Opportunities Fund - Series 9 and up to 444,675 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by 360 One Special Opportunities Fund - Series 10 ("Other Selling Shareholders" and together with the promoter selling shareholders, the "Selling Shareholders" and such offer for sale by the selling shareholders, the "Offer for Sale"). The offer shall constitute 18.87% of the post-offer paid-up equity share capital of the company.
The offer includes a reservation of up to [*] equity shares of face value of Rs.2/- each, aggregating up to Rs. 3.5 crores (Constituting up to [*]% of the post-offer paid-up Equity Share Capital), for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute 18.87% and [*]% of the post-offer paid-up equity share capital of the company, respectively. The company, may in consultation with the brlms, offer a discount of Rs.[*] on the issue price to eligible employees bidding in the employee reservation portion ("Employee Discount").
The face value of the equity shares is Rs.2/- each. The offer price is [*] times the face value of the equity shares.
Price Band: Rs. 438 to Rs. 460 per equity share bearing face value of Rs. 2 each.
The floor price is 219 times the face value bearing the equity shares and the cap price is 230 times the face value of the equity shares.
Bids can be made for a minimum of 32 equity shares of face value of Rs. 2 each and in multiples of 32 equity shares bearing face value of Rs. 2 each thereafter.
A discount of Rs. 41 per equity share is being offered to eligible employees bidding in the employee reservation portion.
|
|
|
|
|
|
|
Nephrocare Health Services Ltd
|
| |
Rs Cr |
Lead Managers to the Issue |
| 0.00 |
| IIFL Capital Services Limited |
| Nomura Financial Advisory & Securities (I) Pvt Ltd |
|
| 846.29 |
|
| 20.07 |
|
| Rs.
438.00
|
|
|
|
|
|
| Projects |
|
Capital expenditure by our Company for opening new dialysis clinics in India
|
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company
|
|
General corporate purposes
| |
|
|
| Vikram Vuppala |
| Bessemer Venture Partners Trus |
| Edoras Investment Holdings Pte |
|
|
|
| |
|
|